Literature DB >> 28285863

Low dose ketamine use in the emergency department, a new direction in pain management.

A Pourmand1, M Mazer-Amirshahi2, C Royall3, R Alhawas3, R Shesser3.   

Abstract

There is a need for alternative non-opioid analgesics for the treatment of acute, chronic, and refractory pain in the emergency department (ED). Ketamine is a fast acting N-methyl-d-aspartate (NMDA) receptor antagonist that provides safe and effective analgesia. The use of low dose ketamine (LDK) (<1mg/kg) provides sub-dissociative levels of analgesia and has been studied as an alternative and/or adjunct to opioid analgesics. We reviewed 11 studies using LDK either alone or in combination with opioid analgesics in the ED. Ketamine was shown to be efficacious at treating a variety of painful conditions. It has a favorable adverse effect profile when given at sub-dissociative doses. Studies have also compared LDK to opioids in the ED. Although ketamine's analgesic effects were not shown to be superior, they were comparable to opioids. LDK has the benefit of causing less respiratory depression. It likely has less wide spread potential for abuse. Nursing protocols for the administration of LDK have been studied. We believe that LDK has the potential to be a safe and effective alternative and/or adjunct to opioid analgesics in the ED. Additional studies are needed to expand upon and determine the optimal use of LDK in the ED.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28285863     DOI: 10.1016/j.ajem.2017.03.005

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN: 0735-6757            Impact factor:   2.469


  7 in total

Review 1.  The Evolving Landscape of Acute Pain Management in the Era of the Opioid Crisis.

Authors:  Ali Pourmand; Gregory Jasani; Courtney Shay; Maryann Mazer-Amirshahi
Journal:  Curr Pain Headache Rep       Date:  2018-08-27

2.  Ketamine sensitization: Influence of dose, environment, social isolation and treatment interval.

Authors:  Keith A Trujillo; Colleen Y Heller
Journal:  Behav Brain Res       Date:  2019-10-05       Impact factor: 3.332

Review 3.  Refractory symptoms in paediatric palliative care: can ketamine help?

Authors:  Franca Benini; Sabrina Congedi; Luca Giacomelli; Simonetta Papa; Aashni Shah; Gregorio Milani
Journal:  Drugs Context       Date:  2021-05-19

4.  LncRNA LINC00641 Sponges miR-497-5p to Ameliorate Neural Injury Induced by Anesthesia via Up-Regulating BDNF.

Authors:  Qingxia Chen; Jingjia Yan; Wenji Xie; Wenqin Xie; Meijun Li; Yanle Ye
Journal:  Front Mol Neurosci       Date:  2020-06-30       Impact factor: 5.639

5.  Additive Effects of Environmental Enrichment and Ketamine on Neuropathic Pain Relief by Reducing Glutamatergic Activation in Spinal Cord Injury in Rats.

Authors:  W L Tai; L Sun; H Li; P Gu; E A Joosten; C W Cheung
Journal:  Front Neurosci       Date:  2021-03-22       Impact factor: 4.677

6.  Low-Dose Ketamine Infusion Versus Morphine Infusion During Abdominoplasty to Change the Postoperative Pain Profile.

Authors:  Hassan Ali; Ahmed Abdelaziz Ismail; Amr Samir Wahdan
Journal:  Anesth Pain Med       Date:  2020-12-19

7.  Low-dose Oral Ketamine as a Procedural Analgesia in Pediatric Cancer Patients Undergoing Bone Marrow Aspirations at a Resource-limited Cancer Hospital in India.

Authors:  Spandana Rayala; Melker Kyander; Vikranth Haridass; Gayatri Palat; Axel Ström; Thomas Wiebe; Eva Brun; Mikael Segerlantz
Journal:  Indian J Palliat Care       Date:  2019 Oct-Dec
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.